BIOLOGICAL WARFARE DEFENSE AGAINST ANTHRAX AND BOTULINUM

File: 120396_sep96_decls57_0007.txt
Page: 0007
Total Pages: 16

Subject: BIOLOGICAL WARFARE DEFENSE AGAINST ANTHRAX AND BOTULINUM        

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003203

Folder Title: INTERIM MEDICAL DOCTRINE BW DEFENSE AGAINST ANTHRAX                                             

Document Number:          1

Folder SEQ  #:          7









                                                               CN


                                                      MEDICAL DOCRRM
                                         BIOUGICAL             (EW)
                                                          AND           TOXIN
                                           F'CR OPERATICN

               1.1 The pr@        defensive           against all forms of EW agents are
               irxiivi@ protection (dimical protective overganwrit/battle dress
               ov          ) , collect3.ve         on. @ @cators when these
               shmld be            is dependeryt upon the BW          on and           system.

               1.2 Medical Proteation - The best                    protection is imnmization.
               Pbr Operat:Lcn Desert Shield, thobe servioe              (SM iderTt:Lfied as "at
               risk" should be vaccimted with anthrax vaccim and botulmm toxoid.

               1.3 Treatmerit - Antibiotics in conjunction with imumizaticn (either pr@
               or booster) or antitoxin provide protection              anthrax and
               botulb= toxin, respectively, followim exposure. These @lities are most
               effective prior to onsl-t of clwcal :Lllness.

               1.4 The overall plan for U.S. BW Deferise              anthr-ax and batal@
               threats for Cperaticn Desert Shield ccns@ of the followim initiatives:

                    a. Vaor-imte servioe              (SM) aga@ anthrax and botulum toxin
               acoo@ to priority establish by

                    b. Issie to          St4 in          a five day slrpply of the Ciprofloxacin
               (Cipro) antibiotic for post             treatment of anthrax. Position in the
               Area of         ibility (ADR) or have   ready sufficieryt C3.pro and
               arytibiat:Lcs for anthrax treatmerrt.

                    c.         iticn the               stock of anthrax vaccim at select
facilities/Med:Lcal   Supply, Cptical, and
                        within the ACR for the express purpose of vaocimtlm exposed @ who
               have rx)t developed symptoms. Anthrax vaocimtlon and dosim with Cipro or
               other appropriate ant2biotic must be a=Wlished together as the treatmer-rt
               for anthr-ax.

                    d.         it:Lcn the              stock of botulmm antitoxin at select
               medical treatment facilities within the AIOR for            te treatmlnt of
               botul@           t:Les.

                    e.        l@ the BW Detection,               and SanpliM System in CENTCCM
               with its central. NBC Oall arxi lower level NBC system coordimtuq rapid
               informticn colleaucn and               ticn.






                                                         1-1

Document 16 f:/Week-36/BX003203/INTERIM MEDICAL DOCTRINE BW DEFENSE AGAINST ANTHRAX/biological warfare defense against anthrax and b:11229616342415
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = INTERIM MEDICAL DOCTRINE BW DEFENSE AGAINST ANTHRAX
Folder Seq # = 7
Subject = BIOLOGICAL WARFARE DEFENSE AGAINST ANTHRAX AND B
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 22-NOV-1996